Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor

Wang, Z; Stuckey, DJ; Murdoch, CE; Camelliti, P; Lip, GYH; Griffin, M; (2018) Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor. Cell Death and Disease , 9 (6) , Article 613. 10.1038/s41419-018-0573-2 . Green open access

https://ift.tt/2Lqnk6t